Australia's Somnomed hits one-week high on Q4 revenue jump

SomnoMed

27/07/2021 05:51

** Shares of Somnomed Ltd  SOM.AX  jump as much as 6.3% to
A$2.38, their highest since July 19 
    ** Somnomed, a co that treats sleep-related disorders
through oral devices, says Q4 revenue rose 91% to A$16.2 mln
($11.96 mln) from a year earlier   urn:newsml:reuters.com:*:nASX5MzGdV
    ** Says co is well-positioned to benefit as market
normalises over coming quarters and deferred patient engagement
returns after COVID-19 delays
    ** Stock posts its biggest intraday pct gain since March 24
    ** SOM stock up 6.7% this year, as of last close
    
    ($1 = 1.3548 Australian dollars)

 (Reporting by Harish Sridharan in Bengaluru)
 ((harish.sridharan@thomsonreuters.com))